Immunotherapy and the heart: Understanding the cardiovascular risks of immune checkpoint inhibitors.

Saved in:
Bibliographic Details
Title: Immunotherapy and the heart: Understanding the cardiovascular risks of immune checkpoint inhibitors.
Authors: Andres MS; Cardio-Oncology Centre of Excellence, Royal Brompton Hospital, London, UK. Electronic address: mariasol.andres@nhs.net., Llamedo MC; Cardio-Oncology Centre of Excellence, Royal Brompton Hospital, London, UK., Ramalingam S; Cardio-Oncology Centre of Excellence, Royal Brompton Hospital, London, UK., Lyon AR; Cardio-Oncology Centre of Excellence, Royal Brompton Hospital, London, UK.
Source: Presse medicale (Paris, France : 1983) [Presse Med] 2026 Jun; Vol. 55 (2), pp. 104327. Date of Electronic Publication: 2025 Nov 21.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Masson Country of Publication: France NLM ID: 8302490 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-0276 (Electronic) Linking ISSN: 07554982 NLM ISO Abbreviation: Presse Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2213-0276
DOI:10.1016/j.lpm.2025.104327